Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WAP four-disulfide core domain protein 2 (WFDC2), commonly known as Human Epididymis Protein 4 (HE4), is a small, secreted glycoprotein belonging to the whey acidic protein (WAP) family. Under normal physiological conditions, its expression is highly restricted, primarily found in the epithelia of the reproductive tract and respiratory system, where it plays a role in epithelial homeostasis, airway barrier development, and innate defense. However, WFDC2 is markedly overexpressed in several malignancies, most notably ovarian and endometrial cancers, where it promotes tumor cell proliferation, migration, invasion, and chemoresistance. It acts as an extracellular signaling ligand that modulates key pathways such as EGFR/MAPK, PI3K/AKT, and JAK/STAT3, and also contributes to an immunosuppressive tumor microenvironment by inducing PD-L1 expression. Clinically, HE4 is widely utilized as an FDA-approved serum biomarker for monitoring ovarian cancer recurrence and, in combination with CA125, in the Risk of Ovarian Malignancy Algorithm (ROMA). Due to its critical role in tumor progression and drug resistance, WFDC2 has emerged as a promising therapeutic target, with investigational strategies including small-molecule inhibitors (such as UR238), siRNA-mediated gene silencing, and monoclonal antibodies currently under preclinical evaluation.
Inhibition of WFDC2/HE4 expression and secretion via proteasome inhibition (UR238), gene silencing via RNA interference (HE4 siRNA), blockade of nuclear translocation via importin inhibition (Ivermectin), and transcriptional downregulation (Ketoprofen).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WAP four-disulfide core domain protein 2 (WFDC2).